Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-30 5:07 pm Purchase |
2023-03-28 | 13D | Acrivon Therapeutics, Inc. Common Stock ACRV |
RA Capital Management, L.P. | 4,817,359 22.000% |
3,917 (+0.08%) |
Filing History |
| 2023-03-30 5:02 pm Purchase |
2023-03-28 | 13D | 89bio, Inc. ETNB |
RA Capital Management, L.P. | 12,876,898 18.000% |
3,500,496 (+37.33%) |
Filing History |
| 2023-03-29 5:14 pm Purchase |
2023-03-27 | 13D | DICE Therapeutics, Inc. DICE |
RA Capital Management, L.P. | 7,660,615 16.100% |
811,704 (+11.85%) |
Filing History |
| 2023-03-27 5:00 pm Purchase |
2023-03-15 | 13G | CureVac N.V. CVAC |
RA Capital Management, L.P. | 12,245,955 5.500% |
12,245,955 (New Position) |
Filing History |
| 2023-03-20 4:30 pm Purchase |
2023-03-10 | 13G | Orchard Therapeutics plc ORTX |
RA Capital Management, L.P. | 18,564,300 9.990% |
18,564,300 (New Position) |
Filing History |
| 2023-02-27 4:57 pm Purchase |
2023-02-23 | 13G | IMARA Inc. IMRA |
RA Capital Management, L.P. | 2,122,465 5.200% |
1,309,784 (+161.17%) |
Filing History |
| 2023-02-24 4:30 pm Purchase |
2023-02-14 | 13D | Mineralys Therapeutics, Inc. MLYS |
RA Capital Management, L.P. | 3,180,920 7.800% |
3,180,920 (New Position) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Third Harmonic Bio, Inc. THRD |
RA Capital Management, L.P. | 534,687 1.300% |
534,687 (New Position) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Celcuity Inc. CELC |
RA Capital Management, L.P. | 2,249,421 9.900% |
762,950 (+51.33%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
RA Capital Management, L.P. | 6,957,179 12.200% |
-610,721 (-8.07%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
RA Capital Management, L.P. | 5,199,746 9.990% |
1,689,643 (+48.14%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | GH Research PLC GHRS |
RA Capital Management, L.P. | 4,898,373 9.400% |
2,054,616 (+72.25%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Kinnate Biopharma Inc. KNTE |
RA Capital Management, L.P. | 4,264,144 9.700% |
671,092 (+18.68%) |
Filing History |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
RA Capital Management, L.P. | 5,516,067 9.800% |
645,000 (+13.24%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | ImmunoGen, Inc. IMGN |
RA Capital Management, L.P. | 22,075,158 9.990% |
-87,800 (-0.40%) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | 5:01 Acquisition Corp. FVAM |
RA Capital Management, L.P. | 0 0.000% |
-750,000 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Pardes Biosciences, Inc. PRDS |
RA Capital Management, L.P. | 0 0.000% |
-4,431,901 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Synlogic, Inc. SYBX |
RA Capital Management, L.P. | 0 0.000% |
-444,444 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Adicet Bio, Inc. ACET |
RA Capital Management, L.P. | 0 0.000% |
-2,364,351 (Position Closed) |
Filing History |
| 2023-02-14 4:45 pm Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
RA Capital Management, L.P. | 0 0.000% |
-3,588,081 (Position Closed) |
Filing History |